CRT 2026

FOCUS ON SHEATHS, ACCESS, CLOSE, WIRES AND CROSSING CATHETERS, RADIAL TO PERIPHERAL

Facilitator(s)

• 

  George Chrysant, MD

  Chief Medical Officer
  INTEGRIS Cardiovascular Physicians, LLC
  Oklahoma City, Oklahoma, United States

  Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Consulting Fees (e.g., advisory boards) (Ongoing); Acarix: Chief Medical Advisor (Ongoing); philips,shockwave,penumbra: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Eric J. Dippel, MD

  Interventional Cardiologist
  Vascular Institute of the Midwest, PC
  Bettendorf, Iowa, United States

  Disclosure information not submitted.
• 

  Zola M. N'Dandu, MD

  Interventional Cardiology and Endovascular Specialist
  MILLU Cardiovascular Wellness
  St Augustine, Florida, United States

  Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific, Terumo: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
• 

  Peter A. Soukas, MD, FSCAI

  Director, Vascular Medicine & Interventional PV Lab
  Brown University Health Cardiovascular Institute/ Brown Medical School
  Providence, Rhode Island, United States

  Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific, Endologix, Contego Medical: Consulting Fees (e.g., advisory boards) (Ongoing); Penumbra, BD, Boston Scientific, Medtronic, Philips, Shockwave, Gore, r3Vascular, Akura, Cagent Vascular, AcoArt, Contego Medical, InspireMD, AVS, Fastwave, .Cordis, Reva Medical,: Grant/Research Support (Ongoing)